-
August 19, 2021 Field Trip Health Expands Access to Ketamine-Assisted PsychotherapyAlthough based in Canada, the company is building a clinical network of therapists trained in...
-
August 18, 2021 Revive Therapeutics Is Exploring This Mushroom’s Potential to Treat Aggressive Breast CancerThe company is also pursuing psilocybin as a possible treatment for rare cancers, but they...
-
August 11, 2021 Nushama Opens Psychedelic Wellness Clinics in NYCThe clinics provide high-dose ketamine infusions, as well as intramuscular ketamine infusions for group therapy.
-
August 4, 2021 Fireside Project Releases App for Psychedelic Peer Support"Our app was designed with accessibility and ease of use as top priorities, so that...
-
July 26, 2021 Akome Biotech Patents Psychedelic Drug Formulation to Treat Parkinson’s DiseaseThere is currently no known cure for the disease affecting 10 million people worldwide, but...
-
July 23, 2021 How a Psilocybin Study on AIDS Survivors Could Solve a Big Problem with Psychedelic TherapyA group psilocybin study paves the way for increased scalability of novel treatments that typically...
-
July 21, 2021 Wake Network Partners with Lieber Institute to Develop Genetics-Based Screening System for Psychedelic TherapiesFungi bioscience company describes the project as “one of the most robust genetics research initiatives...
-
July 20, 2021 Free Ketamine Treatment Now Available for Canadian VeteransMedavie Blue Cross partners with medical research company Braxia Scientific to cover ketamine care for...
-
July 16, 2021 How Wesana Health CEO Daniel Carcillo Plans to Protect Athletes From Traumatic Brain InjuryAnd why the two-time Stanley Cup champion does not imagine working with the NHL in...
-
July 15, 2021 COVID-19 Pandemic Study of Ketamine Therapy Amplifies Antidepressant PotentialStudy authors even believe "treating serious mental illness may reduce adverse outcomes related to COVID-19."
